title: Clearing of melanoma in situ with intralesional interferon alfa in a patient with xeroderma pigmentosum.
authors.affiliation: National Cancer Institute, Bethesda, Md.
authors.forename: M L
authors.initials: ML
authors.lastname: Turner
authors.forename: A N
authors.initials: AN
authors.lastname: Moshell
authors.forename: D W
authors.initials: DW
authors.lastname: Corbett
authors.forename: J B
authors.initials: JB
authors.lastname: Stern
authors.forename: M J
authors.initials: MJ
authors.lastname: Roth
authors.forename: J
authors.initials: J
authors.lastname: DiGiovanna
authors.forename: T D
authors.initials: TD
authors.lastname: Horn
authors.forename: K H
authors.initials: KH
authors.lastname: Kraemer
mesh_terms: D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000008:administration & dosage*; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000628:therapy*; D014983:Xeroderma Pigmentosum / Q000628:therapy*
chemical_list: D016898:Interferon-alpha